Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

About JACC CME
Hardware/Software Requirements
Contact Us
Policy on Privacy and Confidentiality
Copyright Information

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
2009 Focused Updates: ACC/AHA Guidelines for STEMI and ACC/AHA/SCAI Guidelines for PCI
2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery
ACC 2009 Advocacy Position Statement: Principles for Comparative Effectiveness Research
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1265-1271, doi:10.1016/j.jacc.2007.02.021
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v49,p1902)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adriaenssens, T.
Right arrow Articles by Schömig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adriaenssens, T.
Right arrow Articles by Schömig, A.

Does Addition of Estradiol Improve the Efficacy of a Rapamycin-Eluting Stent?

Results of the ISAR-PEACE Randomized Trial

Tom Adriaenssens, MD, Julinda Mehilli, MD*, Rainer Wessely, MD, Gjin Ndrepepa, MD, Melchior Seyfarth, MD, Anna Wieczorek, Birgit Blaich, PhD, Raisuke Iijima, MD, Jürgen Pache, MD, Adnan Kastrati, MD1 and Albert Schömig, MD2

Deutsches Herzzentrum, Technische Universtität, Munich, Germany.


Figure 1
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1 Release Kinetics of Rapamycin From the ERES and RES

Kinetics are displayed as cumulative release of rapamycin over time in percent of total rapamycin on the stents (± SD). ERES = estradiol plus rapamycin-eluting stent; RES = rapamycin-eluting stent.

 

Figure 2
View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 2 Flow Chart of Study Participants

 

Figure 3
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 3 Cumulative Frequency Curves of In-Stent Late Lumen Loss at Follow-Up Angiography for the 2 DES Groups

DES = drug-eluting stent; other abbreviations as in Figure 1.

 

Figure 4
View larger version (38K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 4 Incidences of Angiographic and Clinical Restenosis for the ERES and RES Groups

TLR = target lesion revascularization; other abbreviations as in Figure 1.

 

Figure 5
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 5 Probability of Survival Free of MI for the ERES Group and for the RES Group

MI = myocardial infarction; other abbreviations as in Figure 1.

 
 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement